You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.

Novel Technologies for Treating Neovascular Age-Related Macular Degeneration

Authors: Dante J. Pieramici, MD; Veeral Sheth, MD, MBA; Armin Wolf, MDFaculty and Disclosures


Posted: 03/11/2022

This activity is intended for an international audience of non-US ophthalmologists, other eye care professionals, and all physicians who care for patients with neovascular age-related macular degeneration (nAMD).

Upon completion of this activity, participants will be able to:

  • Have increased knowledge regarding the
    • Latest data on investigational surgical therapies for nAMD
    • Patient selection for anti-VEGF implant therapy
    • Key aspects to improve patient safety when treating patients with an anti-VEGF implant

Educational Impact Challenge

The goal of this activity is for learners to be better able to select patients with nAMD who might benefit from anti-VEGF implant therapy, based on clinical data and best practices.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print